Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Saved in:
| Title: | Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study. |
|---|---|
| Authors: | Verbeek MWC; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Buracchi C; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza (MB), Italy., Laqua A; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Sedek L; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Flores-Montero J; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Hofmans M; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., Sobral de Costa E; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Nováková M; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Mejstrikova E; CLIP-Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Barrena S; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Kohlscheen S; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Szczepanowski M; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Kulis J; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Oliveira E; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Jugooa R; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., de Jong AX; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Szczepanski T; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.; Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia in Katowice, Katowice, Poland., Philippé J; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium.; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium., van Dongen JJM; Department of Immunohematology and Blood Transfusion (IHB), University Medical Center (LUMC), Leiden, the Netherlands., Orfao A; Translational and Clinical Research program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Brüggemann M; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Gaipa G; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza (MB), Italy., van der Velden VHJ; Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. |
| Source: | British journal of haematology [Br J Haematol] 2022 Apr; Vol. 197 (1), pp. 76-81. Date of Electronic Publication: 2021 Dec 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
